Empagliflozin vs Memantine
Empagliflozin vs Memantine: Overview
This comparison examines the pharmacological differences between Empagliflozin and Memantine.
Mechanism of Action
Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.
Memantine: Non-competitive NMDA receptor antagonist.
Pharmacokinetics
Half-life: Empagliflozin β 12.4 hours; Memantine β 60-80 hours.
Chemical Properties
Molecular Formula: Empagliflozin β C23H27ClO7; Memantine β C12H21N.
Molecular Weight: Empagliflozin β 450.9100 g/mol; Memantine β 179.3080 g/mol.
Type: Empagliflozin β Small molecule; Memantine β Small molecule.